Sponsor Pipeline

Brixton Biosciences, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-05 NCT07568015
ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain		 Recruitment opened
Active Trials by Phase
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07568015 ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain Greater Trochanteric Pain Syndrome Recruiting
NCT06700109 INJECTABLE COLD ENERGY THERAPY FOR THE MANAGEMENT OF CHRONIC PAIN ASSOCIATED WITH… Osteoarthritis (OA) of the Knee Active, Not Recruiting
Get alerts when Brixton Biosciences, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free